Is Neoleukin Therapeutics, Inc. (NLTX) a Buy, Sell, or Hold?
NASDAQ : NLTX
Neoleukin Therapeutics, Inc. — Insider Trades
$3.49 USD
$0.05 (1.45%)
- Volume
- 109.1K
- Average Volume
- 6.08K
- Market Capitalization
- $8.2M
- P/E Ratio
- -4.42
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $18.80
- Year Low
- $3.42
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.64
Insider Activity Summary (Last 12 Months)
Insiders Buying
35
Insiders Selling
22
Amount of Insider Selling
$853.25K
NLTX Insider Buying/Selling by Quarter
NLTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Woods Robert Keith | director | 2024-01-16 | A-Award | 32.3 | 2024-01-18 |
| PALEKAR ROHAN | director | 2024-01-16 | A-Award | 32.3 | 2024-01-18 |
| Noonberg Sarah B. | director | 2024-01-16 | A-Award | 32.3 | 2024-01-18 |
| Freedland Cory S. | director | 2024-01-16 | A-Award | 32.3 | 2024-01-18 |
| BAFFI ROBERT | director | 2024-01-16 | A-Award | 32.3 | 2024-01-18 |
| Jordan Julie | officer: Chief Medical Officer | 2024-01-16 | A-Award | 32.3 | 2024-01-18 |
| Jordan Julie | 2024-01-16 | 0 | 2024-01-18 | ||
| Cvijic Christine Mikail | officer: President and CFO | 2023-12-18 | 0 | 2023-12-26 | |
| Cvijic Christine Mikail | officer: President and CFO | 2023-12-18 | 18.39 | 2023-12-26 | |
| Cvijic Christine Mikail | officer: President and CFO | 2023-12-18 | 5.82 | 2023-12-26 | |
| Cvijic Christine Mikail | officer: President and CFO | 2023-12-18 | 10.71 | 2023-12-26 | |
| Cvijic Christine Mikail | officer: President and CFO | 2023-12-18 | 23.02 | 2023-12-26 | |
| McMinn Rachel | director, officer: Chief Executive Officer | 2023-12-18 | 0 | 2023-12-26 | |
| McMinn Rachel | director, officer: Chief Executive Officer | 2023-12-18 | 6.4 | 2023-12-26 | |
| McMinn Rachel | director, officer: Chief Executive Officer | 2023-12-18 | 20.22 | 2023-12-26 | |
| McMinn Rachel | director, officer: Chief Executive Officer | 2023-12-18 | 11.79 | 2023-12-26 | |
| McMinn Rachel | director, officer: Chief Executive Officer | 2023-12-18 | 25.32 | 2023-12-26 | |
| Woods Robert Keith | 2023-12-18 | 0 | 2023-12-26 | ||
| BAFFI ROBERT | director | 2023-12-18 | 23.02 | 2023-12-26 | |
| BAFFI ROBERT | director | 2023-12-18 | 18.39 | 2023-12-26 | |
| BAFFI ROBERT | director | 2023-12-18 | 10.71 | 2023-12-26 | |
| Cobb Stuart | officer: Chief Scientific Officer | 2023-12-18 | 10.71 | 2023-12-26 | |
| Cobb Stuart | officer: Chief Scientific Officer | 2023-12-18 | 23.02 | 2023-12-26 | |
| Cobb Stuart | officer: Chief Scientific Officer | 2023-12-18 | 18.39 | 2023-12-26 | |
| Cobb Stuart | officer: Chief Scientific Officer | 2023-12-18 | 5.82 | 2023-12-26 | |
| Freedland Cory S. | 2023-12-18 | 0 | 2023-12-26 | ||
| BAKER BROS. ADVISORS LP | director | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-10-05 | X-InTheMoney | 0.000005 | 2023-10-10 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-10-05 | X-InTheMoney | 0 | 2023-10-10 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-10-05 | X-InTheMoney | 0 | 2023-10-10 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-10-05 | X-InTheMoney | 0.000005 | 2023-10-10 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-08-17 | P-Purchase | 0.6928 | 2023-08-17 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-08-17 | P-Purchase | 0.6924 | 2023-08-17 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-08-16 | P-Purchase | 0.6828 | 2023-08-17 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-08-16 | P-Purchase | 0.6805 | 2023-08-17 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-08-15 | P-Purchase | 0.665 | 2023-08-17 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-08-15 | P-Purchase | 0.6308 | 2023-08-17 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-08-17 | P-Purchase | 0.6928 | 2023-08-17 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-08-17 | P-Purchase | 0.6924 | 2023-08-17 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-08-16 | P-Purchase | 0.6828 | 2023-08-17 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-08-16 | P-Purchase | 0.6805 | 2023-08-17 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-08-15 | P-Purchase | 0.665 | 2023-08-17 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2023-08-15 | P-Purchase | 0.6308 | 2023-08-17 |
| Smith Sean Michael | officer: Interim CFO, Prin Acct Off | 2023-08-10 | M-Exempt | 0 | 2023-08-14 |
| Smith Sean Michael | officer: Interim CFO, Prin Acct Off | 2023-08-11 | S-Sale | 0.6184 | 2023-08-14 |
| Smith Sean Michael | officer: Interim CFO, Prin Acct Off | 2023-08-10 | M-Exempt | 0 | 2023-08-14 |
| BAKER BROS. ADVISORS LP | director | 2023-06-08 | A-Award | 0.79 | 2023-06-12 |
| SIMPSON TODD E | director | 2023-06-08 | A-Award | 0.79 | 2023-06-09 |
| PALEKAR ROHAN | director | 2023-06-08 | A-Award | 0.79 | 2023-06-09 |
| Noonberg Sarah B. | director | 2023-06-08 | A-Award | 0.79 | 2023-06-09 |
| Lavelle Erin | director | 2023-06-08 | A-Award | 0.79 | 2023-06-09 |
| Babler Martin | director | 2023-06-08 | A-Award | 0.79 | 2023-06-09 |
| Patel Priti | 2023-03-31 | M-Exempt | 0 | 2023-04-04 | |
| Patel Priti | 2023-04-03 | S-Sale | 0.6919 | 2023-04-04 | |
| Patel Priti | 2023-03-31 | M-Exempt | 0 | 2023-04-04 | |
| Smith Sean Michael | officer: Principal Accounting Officer | 2023-02-01 | M-Exempt | 0 | 2023-02-03 |
| Smith Sean Michael | officer: Principal Accounting Officer | 2023-02-02 | S-Sale | 0.5972 | 2023-02-03 |
| Smith Sean Michael | officer: Principal Accounting Officer | 2023-02-01 | M-Exempt | 0 | 2023-02-03 |
| Patel Priti | officer: Chief Medical Officer | 2023-02-01 | M-Exempt | 0 | 2023-02-03 |
| Patel Priti | officer: Chief Medical Officer | 2023-02-01 | M-Exempt | 0 | 2023-02-03 |
| Patel Priti | officer: Chief Medical Officer | 2023-02-02 | S-Sale | 0.5972 | 2023-02-03 |
| Smith Sean Michael | officer: Principal Accounting Officer | 2022-08-10 | M-Exempt | 0 | 2022-08-12 |
| Smith Sean Michael | officer: Principal Accounting Officer | 2022-08-10 | S-Sale | 0.9914 | 2022-08-12 |
| Walkey Carl | officer: Senior Vice President | 2022-08-02 | A-Award | 0 | 2022-08-04 |
| Smith Sean Michael | officer: Principal Accounting Officer | 2022-08-02 | A-Award | 0 | 2022-08-04 |
| Patel Priti | officer: Chief Medical Officer | 2022-08-02 | A-Award | 0 | 2022-08-04 |
| DRACHMAN JONATHAN G | officer: President and CEO | 2022-08-02 | A-Award | 0 | 2022-08-04 |
| Cochener Donna | officer: General Counsel, SVP Legal | 2022-08-02 | A-Award | 0 | 2022-08-04 |
| SIMPSON TODD E | director: | 2022-05-12 | A-Award | 0 | 2022-05-16 |
| SIMPSON TODD E | director | 2022-05-12 | A-Award | 1.07 | 2022-05-16 |
| PALEKAR ROHAN | director | 2022-05-12 | A-Award | 1.07 | 2022-05-16 |
| PALEKAR ROHAN | director: | 2022-05-12 | A-Award | 0 | 2022-05-16 |
| Noonberg Sarah B. | director | 2022-05-12 | A-Award | 1.07 | 2022-05-16 |
| Noonberg Sarah B. | director: | 2022-05-12 | A-Award | 0 | 2022-05-16 |
| Lavelle Erin | director: | 2022-05-12 | A-Award | 0 | 2022-05-16 |
| Babler Martin | director: | 2022-05-12 | A-Award | 0 | 2022-05-16 |
| Babler Martin | director | 2022-05-12 | A-Award | 1.07 | 2022-05-16 |
| Baker Bros. Advisors (GP) LLC | director: | 2022-05-12 | A-Award | 0 | 2022-05-16 |
| BAKER BROS. ADVISORS LP | director | 2022-05-12 | A-Award | 1.07 | 2022-05-16 |
| Patel Priti | officer: Chief Medical Officer | 2022-04-30 | M-Exempt | 0 | 2022-05-03 |
| Patel Priti | officer: Chief Medical Officer | 2022-04-30 | S-Sale | 1.2186 | 2022-05-03 |
| Cochener Donna | officer: General Counsel, SVP Legal | 2022-03-14 | A-Award | 0 | 2022-03-15 |
| Cochener Donna | officer | 2022-03-14 | 0 | 2022-03-15 | |
| PALEKAR ROHAN | director: | 2022-03-02 | A-Award | 0 | 2022-03-04 |
| PALEKAR ROHAN | director | 2022-03-02 | A-Award | 2.72 | 2022-03-04 |
| PALEKAR ROHAN | director: | 2022-03-02 | 0 | 2022-03-04 | |
| Smith Sean Michael | officer: Principal Accounting Officer | 2022-03-02 | A-Award | 0 | 2022-03-03 |
| Smith Sean Michael | officer: Principal Accounting Officer | 2022-03-02 | 0 | 2022-03-03 | |
| Smith Sean Michael | officer: Principal Accounting Officer | 2022-03-02 | 12 | 2022-03-03 | |
| Smith Sean Michael | officer: Principal Accounting Officer | 2022-03-02 | 0 | 2022-03-03 | |
| Smith Sean Michael | officer: Principal Accounting Officer | 2022-03-02 | 2.71 | 2022-03-03 | |
| Smith Sean Michael | officer: Principal Accounting Officer | 2022-03-02 | 6.8 | 2022-03-03 | |
| DRACHMAN JONATHAN G | director, officer: President and CEO | 2021-12-31 | 0 | 2022-02-14 |